Access cutting-edge prostate cancer metastatic treatment through this phase 2 clinical trial at a research site in Washington D.C.. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Washington D.C. location
Preparing your pre-screening questions…
Access prostate cancer metastatic specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer metastatic treatment provided free
Check if you qualify for this prostate cancer metastatic clinical trial in Washington D.C., DC
No-Cost Study Care
Local to Washington D.C.
Convenient for DC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Use of Enhertu as a Subsequent Line of Therapy in HER2-Positive Metastatic Castration-Resistant Prostate Adenocarcinoma.
Sponsor: Washington D.C. Veterans Affairs Medical Center
Yes, this clinical trial (NCT06610825) has an active research site in Washington D.C., DC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for prostate cancer metastatic treatment options in Washington D.C., DC, this clinical trial (NCT06610825) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington D.C. research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced prostate cancer metastatic specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all prostate cancer metastatic clinical trials near you to find additional studies recruiting in your area.
See all prostate cancer clinical trials recruiting in Washington D.C. — not just this study.
Browse Prostate Cancer Trials in Washington D.C. →